TAGRAXOFUSP TREATMENT OF PEDIATRIC BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

被引：0
|
作者：
Zhao, Quan [1 ]
Kheradpour, Albert [1 ]
机构：
[1] Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [1] Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm
    Hammond, Danielle
    Pemmaraju, Naveen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (03) : 565 - +
  • [2] Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
    Luskin, Marlise R.
    Lane, Andrew A.
    HAEMATOLOGICA, 2024, 109 (01) : 44 - 52
  • [3] Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm
    Lee, Sophia S.
    McCue, Deborah
    Pemmaraju, Naveen
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 543 - 550
  • [4] Tagraxofusp Treatment Implications for patients with blastic plasmacytoid dendritic cell neoplasm
    Morin, Allison
    Kechedjian, Flora
    Walton, Paige
    Tavakoli, Aran
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (02) : E10 - E16
  • [5] Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Wilson, Nathaniel R.
    Pemmaraju, Naveen
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (04) : 431 - 438
  • [6] Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
    Pemmaraju, Naveen
    Lane, Andrew A.
    Sweet, Kendra L.
    Stein, Anthony S.
    Vasu, Sumithira
    Blum, William
    Rizzieri, David A.
    Wang, Eunice S.
    Duvic, Madeleine
    Sloan, J. Mark
    Spence, Sharon
    Shemesh, Shay
    Brooks, Christopher L.
    Balser, John
    Bergstein, Ivan
    Lancet, Jeffrey E.
    Kantarjian, Hagop M.
    Konopleva, Marina
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (17): : 1628 - 1637
  • [7] Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm
    Diaz Acedo, Rocio
    Dominguez Munoz, Maria Angeles
    Navajas Laguna, Clara
    Morales Camacho, Rosario
    Simon Pilo, Isabel
    Calama Ruiz-Mateos, Virgilio Pablo
    Yebenes Ramirez, Manuel
    Vahi Sanchez de Medina, Maria
    Artacho Criado, Silvia
    Rodriguez Perez, Aitana
    Couto Caro, Maria Carmen
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1762 - 1764
  • [8] Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Alfayez, Mansour
    Konopleva, Marina
    Pemmaraju, Naveen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 115 - 123
  • [9] Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
    Pemmaraju, Naveen
    Konopleva, Marina
    BLOOD ADVANCES, 2020, 4 (16) : 4020 - 4027
  • [10] Tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a profile of its use
    Anthony Markham
    Drugs & Therapy Perspectives, 2021, 37 : 557 - 562
12345